NCT06604858
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06604858
Title Neoadjuvant Pembrolizumab and Carboplatin Plus Paclitaxel for Stage I Triple-negative Breast Cancer (TELESCOPE)
Acronym TELESCOPE
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors MedSIR
Indications
Therapies
Age Groups: senior | adult
Covered Countries ESP

Facility Status City State Zip Country Details
Complejo Hospitalario Universitario A Coruña (CHUAC) RECRUITING A Coruña Spain Details
Hospital Universitari Dexeus RECRUITING Barcelona Spain Details
Hospital Universitari Vall D'Hebron RECRUITING Barcelona Spain Details
Institut Català d' Oncologia Girona (ICO) RECRUITING Girona Spain Details
Hospital Universitario Clínico San Cecilio de Granada RECRUITING Granada Spain Details
Hospital Beata María Ana RECRUITING Madrid Spain Details
Hospital Cínico San Carlos RECRUITING Madrid Spain Details
Hospital Universitario de Navarra RECRUITING Pamplona Spain Details
Complejo Hospitalario Universitario de Santiago (CHUS) RECRUITING Santiago de Compostela Spain Details
Hospital Universitario Virgen del Rocío RECRUITING Seville Spain Details
Hospital Arnau de Vilanova de Valencia RECRUITING Valencia Spain Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field